Chavez-MacGregor M, Miao J, Pusztai L, Goetz MP, et al. Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy +/- 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. J Clin Oncol 2024 Jun 4:JCO2302344. doi: 10.1200/JCO.23.02344.
PMID: 38833643